Additionally, orlistat or FASN siRNA treatment increased cell cytotoxicity and cell sensitivity to radiotherapy in the radioresistant HNSCC cell line rSCC-61 (83). The gene discussed is FASN; the disease is head and neck squamous cell carcinoma.